Provided by Tiger Fintech (Singapore) Pte. Ltd.

Mira Pharma

1.87
+0.210012.65%
Post-market: 1.87-0.0010-0.05%19:59 EDT
Volume:2.68M
Turnover:4.83M
Market Cap:31.64M
PE:-3.76
High:1.91
Open:1.68
Low:1.66
Close:1.66
Loading ...

MIRA Pharmaceuticals Reports Promising SKNY-1 Preclinical Results

TIPRANKS
·
11 Jul

Mira Reports Clear Reversal of Anxiety-Related Behavior in Animal Model Using Skny-1

THOMSON REUTERS
·
11 Jul

Mira Pharmaceuticals- Expects to Initiate Investigational New Drug (Ind)-Enabling Studies for Skny-1

THOMSON REUTERS
·
11 Jul

Mira Pharmaceuticals Inc - Skny-1 Achieves 30% Weight Loss and Reverses Nicotine Craving - SEC Filing

THOMSON REUTERS
·
11 Jul

Mira Pharmaceuticals Announces Promising Preclinical Results for SKNY-1, a New Drug Candidate Targeting Obesity and Nicotine Addiction

Reuters
·
11 Jul

MIRA Pharmaceuticals Raises $2M Through Stock Sale

TIPRANKS
·
09 Jul

Mira Pharmaceuticals Inc. Sells 1,550,741 Shares in Block Sale to Institutional Investor for $2 Million

Reuters
·
09 Jul

Mira Pharmaceuticals Shares up 4.8% at $1.30 Following Positive Preclinical Data From Mira-55

THOMSON REUTERS
·
03 Jul

Mira Pharmaceuticals reports preclinical data on Mira-55 marijuana analog

TIPRANKS
·
03 Jul

Top Premarket Gainers

MT Newswires Live
·
03 Jul

Mira Pharmaceuticals Shares up 30% at $1.62 Premarket Following Positive Preclinical Data From Mira-55

THOMSON REUTERS
·
03 Jul

24H|Mira Pharma Soars 47%; Minim Surges 42%; Datadog Jumps 11%; AppLovin and Robinhood Drop 1%

Tiger Newspress
·
03 Jul

BUZZ-MIRA Pharmaceuticals jumps on positive preclinical data from marijuana-based pain relief drug

Reuters
·
03 Jul

Mira Pharmaceuticals Inc Shares up About 40% at Around $1.74 After the Bell Following Update on Mira-55

THOMSON REUTERS
·
03 Jul

MIRA Pharmaceuticals Announces Promising Preclinical Results for Mira-55

TIPRANKS
·
03 Jul

BRIEF-Mira Pharmaceuticals says Mira-55 Shows Morphine-Comparable Pain Relief Without Opioid Risks

Reuters
·
03 Jul

Mira Pharmaceuticals Inc - Mira-55 Shows Morphine-Comparable Pain Relief Without Opioid Risks - SEC Filing

THOMSON REUTERS
·
03 Jul

MIRA Pharmaceuticals Advances with Regulatory Green Light for Mira-55, Clearing Path for Clinical Development in Pain Management

Reuters
·
03 Jul

BRIEF-Mira Pharmaceuticals Announces New Study Results For SKNY-1 - SEC Filing

Reuters
·
30 Jun

Mira Pharmaceuticals: in Untreated Obese Animals, Fat Buildup in the Liver Was About 50% Higher Than Normal

THOMSON REUTERS
·
30 Jun